248 related articles for article (PubMed ID: 31072208)
1. High-Throughput Quantification of
Xu M; Li J; Xie J; He R; Su Q; Gao G; Tai PWL
Hum Gene Ther; 2019 Aug; 30(8):946-956. PubMed ID: 31072208
[TBL] [Abstract][Full Text] [Related]
2. High-Throughput
Westhaus A; Cabanes-Creus M; Rybicki A; Baltazar G; Navarro RG; Zhu E; Drouyer M; Knight M; Albu RF; Ng BH; Kalajdzic P; Kwiatek M; Hsu K; Santilli G; Gold W; Kramer B; Gonzalez-Cordero A; Thrasher AJ; Alexander IE; Lisowski L
Hum Gene Ther; 2020 May; 31(9-10):575-589. PubMed ID: 32000541
[TBL] [Abstract][Full Text] [Related]
3. Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing.
de Alencastro G; Pekrun K; Valdmanis P; Tiffany M; Xu J; Kay MA
Hum Gene Ther; 2020 May; 31(9-10):553-564. PubMed ID: 32024384
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
[TBL] [Abstract][Full Text] [Related]
5. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
Chamberlain K; Riyad JM; Weber T
Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
[TBL] [Abstract][Full Text] [Related]
6. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM
J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615
[TBL] [Abstract][Full Text] [Related]
7. Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines.
Ryals RC; Boye SL; Dinculescu A; Hauswirth WW; Boye SE
Mol Vis; 2011 Apr; 17():1090-102. PubMed ID: 21552473
[TBL] [Abstract][Full Text] [Related]
8. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
9. Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes.
Dane AP; Wowro SJ; Cunningham SC; Alexander IE
Gene Ther; 2013 Apr; 20(4):460-4. PubMed ID: 22895507
[TBL] [Abstract][Full Text] [Related]
10. Deep Parallel Characterization of AAV Tropism and AAV-Mediated Transcriptional Changes
Brown D; Altermatt M; Dobreva T; Chen S; Wang A; Thomson M; Gradinaru V
Front Immunol; 2021; 12():730825. PubMed ID: 34759919
[TBL] [Abstract][Full Text] [Related]
11. Muscle-Directed Delivery of an AAV1 Vector Leads to Capsid-Specific T Cell Exhaustion in Nonhuman Primates and Humans.
Gernoux G; Gruntman AM; Blackwood M; Zieger M; Flotte TR; Mueller C
Mol Ther; 2020 Mar; 28(3):747-757. PubMed ID: 31982038
[TBL] [Abstract][Full Text] [Related]
12. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
Lieber A; Steinwaerder DS; Carlson CA; Kay MA
J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
[TBL] [Abstract][Full Text] [Related]
13. Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity.
Paulk NK; Pekrun K; Zhu E; Nygaard S; Li B; Xu J; Chu K; Leborgne C; Dane AP; Haft A; Zhang Y; Zhang F; Morton C; Valentine MB; Davidoff AM; Nathwani AC; Mingozzi F; Grompe M; Alexander IE; Lisowski L; Kay MA
Mol Ther; 2018 Jan; 26(1):289-303. PubMed ID: 29055620
[TBL] [Abstract][Full Text] [Related]
14. Early interaction of adeno-associated virus serotype 8 vector with the host immune system following intramuscular delivery results in weak but detectable lymphocyte and dendritic cell transduction.
Gernoux G; Guilbaud M; Dubreil L; Larcher T; Babarit C; Ledevin M; Jaulin N; Planel P; Moullier P; Adjali O
Hum Gene Ther; 2015 Jan; 26(1):1-13. PubMed ID: 25333770
[TBL] [Abstract][Full Text] [Related]
15. Short DNA Hairpins Compromise Recombinant Adeno-Associated Virus Genome Homogeneity.
Xie J; Mao Q; Tai PWL; He R; Ai J; Su Q; Zhu Y; Ma H; Li J; Gong S; Wang D; Gao Z; Li M; Zhong L; Zhou H; Gao G
Mol Ther; 2017 Jun; 25(6):1363-1374. PubMed ID: 28462820
[TBL] [Abstract][Full Text] [Related]
16. Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.
Sen D; Gadkari RA; Sudha G; Gabriel N; Kumar YS; Selot R; Samuel R; Rajalingam S; Ramya V; Nair SC; Srinivasan N; Srivastava A; Jayandharan GR
Hum Gene Ther Methods; 2013 Apr; 24(2):104-16. PubMed ID: 23442071
[TBL] [Abstract][Full Text] [Related]
17. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
18. Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS.
Goodwin MS; Croft CL; Futch HS; Ryu D; Ceballos-Diaz C; Liu X; Paterno G; Mejia C; Deng D; Menezes K; Londono L; Arjona K; Parianos M; Truong V; Rostonics E; Hernandez A; Boye SL; Boye SE; Levites Y; Cruz PE; Golde TE
Mol Neurodegener; 2020 Mar; 15(1):15. PubMed ID: 32122372
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
20. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
